Ingenuity Pathway Analysis (IPA)
QIAGEN OmicSoft and Biomedical Knowledge Base
Novel discoveries from public single-cell RNA-seq data using QIAGEN OmicSoft and QIAGEN Ingenuity...
QIAGEN OmicSoft Lands and QIAGEN Ingenuity Pathway Analysis (IPA) provide a...
QIAGEN OMICSOFT AND BIOMEDICAL KNOWLEDGE BASE
QIAGEN OmicSoft and Biomedical Knowledge Base
Identifying new drug targets and biomarkers for a disease of interest using...
QIAGEN Biomedical KB-HD is the high-quality, expert-curated biomedical knowledge base...
QIAGEN OmicSoft and Biomedical Knowledge Base
Gene set enrichment, target validation and Python-based ‘omics data mining
Learn how to take advantage of QIAGEN Biomedical KB-HD, the high-quality,...
QIAGEN IPA
Easily search and interpret 'omics datasets using OmicSoft Explorer and IPA...
In this webinar, the trainer will cover a highly requested usecase using OmicSoft...
QIAGEN OmicSoft and Biomedical Knowledge Base
ATCC cell line data utilization for cell line selection, validation and other...
Cancer cell line models have been a cornerstone of cancer research for decades....
QIAGEN OmicSoft and Biomedical Knowledge Base
Using OmicSoft OncoLand to integrate public expression
QIAGEN OmicSoft Lands are high-quality curated repositories of genomics and proteomics...
QIAGEN OmicSoft and Biomedical Knowledge Base
Biomarkers and drug target investigation using manually curated, unified...
There is an almost incomprehensible amount of diverse, non-standardized ‘omics data...
QIAGEN OmicSoft and Biomedical Knowledge Base
Mining curated knowledge graphs and validating with experimental datasets to...
In an era of near-limitless public experimental data but little standardization,...
QIAGEN OmicSoft and Biomedical Knowledge Base
Identifying critical drug-to-disease pathways using high-quality curated...
In the drug discovery pipeline, evaluating multiple pathways between a drug target and...
QIAGEN OmicSoft and Biomedical Knowledge Base
Discoveries from deeply curated TCGA expression data using OmicSoft Studio
While there is great interest in the scientific community to investigate drug targets...